WALTHAM,
Mass., Oct. 29, 2024 /PRNewswire/ -- Syndax
Pharmaceuticals (Nasdaq: SNDX), a commercial-stage
biopharmaceutical company developing an innovative pipeline of
cancer therapies, today announced that it will report its third
quarter 2024 financial results and provide a business update on
Tuesday, November 5, 2024.
In connection with the earnings release, Syndax's management
will host a conference call and live audio webcast at 4:30 p.m. ET
on Tuesday, November 5, 2024 to
discuss the Company's financial results and provide a business
update.
The live audio webcast and accompanying slides may be accessed
through the Events & Presentations page in the Investors
section of the Company's website. Alternatively, the conference
call may be accessed through the following:
Conference ID: Syndax3Q24
Domestic Dial-in Number: 800-590-8290
International Dial-in Number: 240-690-8800
Live webcast:
https://www.veracast.com/webcasts/syndax/events/SNDX3Q24.cfm
For those unable to participate in the conference call or
webcast, a replay will be available on the Investors section of the
Company's website at www.syndax.com approximately 24 hours
after the conference call and will be available for 90 days
following the call.
About Syndax
Syndax Pharmaceuticals is a commercial-stage
biopharmaceutical company developing an innovative pipeline of
cancer therapies. Highlights of the Company's pipeline include
revumenib, a selective menin inhibitor, and Niktimvo™
(axatilimab-csfr), an FDA-approved monoclonal antibody that blocks
the colony stimulating factor 1 (CSF-1) receptor. Fueled by our
commitment to reimagining cancer care, Syndax is working to unlock
the full potential of its pipeline and is conducting several
clinical trials across the continuum of treatment. For more
information, please visit www.syndax.com/ or follow the
Company on X (formerly Twitter) and LinkedIn.
Syndax Contact
Sharon Klahre
Syndax Pharmaceuticals, Inc.
sklahre@syndax.com
Tel 781.684.9827
SNDX-G
View original
content:https://www.prnewswire.com/news-releases/syndax-to-announce-third-quarter-2024-financial-results-and-host-conference-call-and-webcast-on-november-5-2024-302286420.html
SOURCE Syndax Pharmaceuticals, Inc.